[PDF][PDF] A lymphotoxin-driven pathway to hepatocellular carcinoma

J Haybaeck, N Zeller, MJ Wolf, A Weber, U Wagner… - Cancer cell, 2009 - cell.com
J Haybaeck, N Zeller, MJ Wolf, A Weber, U Wagner, MO Kurrer, J Bremer, G Iezzi, R Graf…
Cancer cell, 2009cell.com
Hepatitis B and C viruses (HBV and HCV) cause chronic hepatitis and hepatocellular
carcinoma (HCC) by poorly understood mechanisms. We show that cytokines lymphotoxin
(LT) α and β and their receptor (LTβR) are upregulated in HBV-or HCV-induced hepatitis
and HCC. Liver-specific LTαβ expression in mice induces liver inflammation and HCC,
causally linking hepatic LT overexpression to hepatitis and HCC. Development of HCC,
composed in part of A6+ oval cells, depends on lymphocytes and IKappa B kinase β …
Summary
Hepatitis B and C viruses (HBV and HCV) cause chronic hepatitis and hepatocellular carcinoma (HCC) by poorly understood mechanisms. We show that cytokines lymphotoxin (LT) α and β and their receptor (LTβR) are upregulated in HBV- or HCV-induced hepatitis and HCC. Liver-specific LTαβ expression in mice induces liver inflammation and HCC, causally linking hepatic LT overexpression to hepatitis and HCC. Development of HCC, composed in part of A6+ oval cells, depends on lymphocytes and IKappa B kinase β expressed by hepatocytes but is independent of TNFR1. In vivo LTβR stimulation implicates hepatocytes as the major LT-responsive liver cells, and LTβR inhibition in LTαβ-transgenic mice with hepatitis suppresses HCC formation. Thus, sustained LT signaling represents a pathway involved in hepatitis-induced HCC.
cell.com